Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness and safety of pregabalin in patients with epilepsy and anxiety disorder
2005-004074-24Phase 3Completed
- Sponsor
- Gesellschaft für Epilepsieforschung
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of pregabalin in Focal Onset Epilepsy and anxiety disorder, sponsored by Gesellschaft für Epilepsieforschung. Primary endpoint: Seizure reduction of ≥50%. Started Dec 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
Focal Onset Epilepsyanxiety disorder
Beyond the preview
Go deeper on 2005-004074-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004074-24.